香雪品牌怎么样 申请店铺

我要投票 香雪在中草药行业中的票数:413 更新时间:2025-06-17
香雪是哪个国家的品牌?「香雪」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人王永辉在1986期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪品牌出海!将品牌入驻外推网,定制香雪品牌推广信息,可以显著提高香雪产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

香雪怎么样

广州市香雪制药股份有限公司总部位于广州经济技术开发区科学城,是一家以中成药制药和研发为主业,集西药制药、生物医学工程和药材规范种植于一体的现代化高新技术医药企业。

公司秉承“厚生臻善维新”的企业理念,坚持“崇尚品质;关爱健康”的质量方针,坚持自主创新、自主品牌,在品质、技术、研发、品牌和规模等多方面成长为行业领先者,得到消费者、行业和政府主管部门的高度评价和广泛认可,其中“香雪”商标获评中国驰名商标,“香雪抗病毒口服液”获评广东省名牌和广州市名牌产品,香雪制药获评“《福布斯》中国成长企业潜力榜100强”前五位,香雪制药获评“广东省医药产业50强企业”和“广州2010年亚运会药品供应商”等。

香雪制药一直致力于质量创新,致力于中药现代化的研究和实践,1998年开始进行中药现代化关键技术指纹图谱质量控制技术的研究,并取得重大突破。2001年,香雪抗病毒口服液指纹图谱质控研究被纳入广州名优中成药品种指纹图谱质量控制示范研究项目。2000年,香雪制药本着“实施中药系列标准规范,提高中成药品种质量”的理念,承担了国家科技部的“九五”重点科技攻关项目广藿香GAP种植基地,经过一年多的探索与研究,现已被国家科技部列入第一批国家中药现代化科技产业化(广东)基地,并通过国家验收。

香雪制药本着高起点、高技术、高标准、高速度的现代企业发展战略,采用先进的技术、工艺、设备,形成了完善、科学、先进的生产体系,使公司的产品质量和主要技术指标均达到了国内先进水平。公司坚持“创新”为企业的灵魂,以科技进步推动企业的发展。近年来承担了多项国家及省、市级重大科技专项技术的研究与开发;本着生产一代、储备一代、研制一代、构思一代的新产品开发战略。加快了疗效确切、科技含量高的新产品的研制开发。

Guangzhou Xiangxue Pharmaceutical Co., Ltd., headquartered in Science City, Guangzhou Economic and Technological Development Zone, is a modern high-tech pharmaceutical enterprise with Chinese patent medicine and R & D as its main business, integrating western medicine, biomedical engineering and standard planting of medicinal materials. The company adheres to the enterprise concept of "great life, perfect and innovative", and adheres to "advocating quality"; The company adheres to the quality policy of "care for health", adheres to independent innovation and independent brand, grows into the industry leader in quality, technology, R & D, brand and scale, and is highly appraised and widely recognized by consumers, industry and government authorities. Among them, "Xiangxue" trademark is awarded the famous trademark in China, and "Xiangxue antiviral oral liquid" is awarded the famous brand in Guangdong Province and Guangzhou city Brand products, Xiangxue pharmaceutical won the top five "Forbes China growth enterprise potential list top 100", Xiangxue pharmaceutical won the "top 50 pharmaceutical enterprises in Guangdong Province" and "drug supplier of Guangzhou 2010 Asian Games" and so on. Xiangxue pharmaceutical has been committed to quality innovation, research and practice of the modernization of traditional Chinese medicine. In 1998, it began to study the key technology of the modernization of traditional Chinese medicine fingerprint quality control technology, and made a major breakthrough. In 2001, the fingerprint quality control research of Xiangxue antiviral oral liquid was included in the quality control demonstration research project of Guangzhou famous and excellent Chinese patent medicine. In 2000, in line with the concept of "implementing the standards and specifications of traditional Chinese medicine series and improving the quality of traditional Chinese medicine varieties", Xiangxue pharmaceutical undertook the patchouli gap planting base, a key scientific and technological key project of the Ninth Five Year Plan of the Ministry of science and technology of the people's Republic of China. After more than a year's exploration and research, it has been listed in the first batch of national bases for the modernization of science and technology industrialization of traditional Chinese medicine (Guangdong) by the Ministry of science and technology of the people's Republic of China and passed the national acceptance 。 Based on the modern enterprise development strategy of high starting point, high technology, high standard and high speed, Xiangxue pharmaceutical adopts advanced technology, process and equipment to form a perfect, scientific and advanced production system, so that the product quality and main technical indicators of the company have reached the advanced level in China. The company adheres to "innovation" as the soul of the enterprise and promotes the development of the enterprise with the progress of science and technology. In recent years, it has undertaken the research and development of a number of national, provincial and municipal major science and technology special technologies; in line with the new product development strategy of production generation, storage generation, development generation and conception generation. The research and development of new products with precise curative effect and high technology content are accelerated.

本文链接: https://brand.waitui.com/f0447df2d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

港股IPO市场持续火热,“打新”赚钱效应持续

2025年以来,港股IPO市场持续火热,港股“打新”赚钱效应仍在持续。Wind数据显示,2025年以来,港股已有31只新股上市,其中仅9只破发,破发率为29.03%。而在2024年上半年,港股一共有70只新股上市,25只新股破发,破发率为35.71%。综合众多港股新股的表现,发现这些新股首日走强具备四大特征。特征一:热门产业、龙头企业;特征二:赴港上市的A股公司;特征三:基石投资者的质量;特征四:超高申购倍数。(证券时报)

2小时前

亚马逊Kuiper卫星第二次发射因ULA火箭助推器问题推迟

联合发射联盟周一被迫推迟搭载亚马逊Kuiper项目互联网卫星的第二次发射任务,原因是火箭助推器出现问题。(新浪财经)

2小时前

罗马仕召回491745台移动电源

36氪获悉,据深圳市市场监督管理局网站,日前,深圳罗马仕科技有限公司按照《消费品召回管理暂行规定》的要求,向深圳市市场监督管理局报告了召回计划,将自即日起,召回2023年6月5日-2024年7月31日期间制造的部分罗马仕ROMOSS牌移动电源,三款产品共计491745台。本次召回的移动电源产品,由于部分电芯原材料来料原因,极少数产品在使用过程中可能存在过热现象,在极端场景下可能产生燃烧风险,存在安全隐患。深圳罗马仕科技有限公司将为购买到召回范围内产品的消费者免费更换一台全新的、不低于原产品价值且符合安全要求的移动电源产品、或做退货退款处理,以消除安全隐患。

2小时前

物流科技公司Warp融资1000万美元,用于全自动机器人交叉配送中心建设

总部位于洛杉矶的科技物流企业Warp周五宣布,已完成1000万美元A轮融资,将通过机器人技术和自动化手段扩展其AI驱动的货运网络。该公司在新闻稿中称,本轮融资由Up.Partners和Blue Bear Capital领投,至此Warp自2021年成立以来的总融资额达2200万美元。新资金将用于支持Warp的AI系统开发,以及首个全机器人交叉配送中心的落地。该公司表示,这座自动化设施将实现从入库接收到出库调度的全货运周期自动化。(新浪财经)

2小时前

加拿大总理卡尼:美国和加拿大将争取在30天内达成贸易协议

加拿大总理马克·卡尼在X上发帖称,他和美国总统唐纳德·特朗普同意在未来30天内推进谈判以达成贸易协议。卡尼还表示,两国重点关注全球性挑战和当前贸易压力,包括构建加拿大和美国之间新型经济和安全关系的优先事项。(新浪财经)

2小时前

本页详细列出关于香雪的品牌信息,含品牌所属公司介绍,香雪所处行业的品牌地位及优势。
咨询